Opportunity Information: Apply for BAA ROAA ENDTB 2019
USAID/New Delhi released the "Accelerator to End TB in India" Broad Agency Announcement (BAA) to find partners willing to jointly build and test new approaches that can help India reach its goal of eliminating tuberculosis by 2025. Rather than funding a pre-defined program with fixed activities, this opportunity is set up to attract strong ideas first and then work side-by-side with selected organizations to co-create and co-design solutions. The emphasis is on research and development interventions that can be demonstrated quickly and evaluated rigorously, with an expectation that the resulting evidence can drive real-world adoption at scale.
The central program purpose is to accelerate reductions in TB in India through person-centered, high-impact, and novel solutions, with a particular focus on multidrug-resistant and rifampicin-resistant TB (MDR/RR-TB). USAID signals that incremental improvements are not the goal; they are explicitly looking for "out-of-the-box, but achievable" approaches that can leapfrog conventional models for TB prevention, diagnosis, and treatment. In practice, this points to innovations that can materially improve the patient journey (from risk and screening through diagnosis, treatment initiation, adherence, and outcomes) and that can show measurable improvements under real service delivery conditions.
USAID highlights several thematic areas of interest. One is strengthening the enabling environment, which can include policy, financing, regulation, data use, procurement and supply chains, quality standards, and coordination across public and private sectors. Another is enhancing service delivery platforms, meaning solutions that improve how TB services are organized and delivered (for example, more effective referral pathways, differentiated care models, improved diagnostic access, stronger treatment support, or integration with other health services). USAID also stresses integrating modern behavior change approaches with scientific or technological advances, suggesting they want solutions that combine human-centered design and behavioral insights with tools like diagnostics, digital systems, or other innovations, rather than technology alone.
Equity and access are positioned as non-negotiable for long-term success. The BAA calls for a clear understanding of how TB services will be made accessible for everyone, including priority and vulnerable populations. It also emphasizes building diverse local partnerships to catalyze implementation, reflecting a preference for approaches that are grounded in local realities and that can work within India’s TB ecosystem across government, private providers, communities, and other stakeholders.
A defining feature of this BAA is co-investment. USAID wants partners who will share responsibility, risk, and resources to reach agreed outcomes. Resource contributions can be cash or non-cash and may include in-kind support, staff expertise, intellectual property, brand value, coordination capacity, and access to key networks, institutions, geographies, or data. Importantly, USAID does not require a 1:1 match; the expectation is that each party contributes resources that make sense for the specific project and reflect their comparative advantage.
From an applicant standpoint, eligibility is broadly open ("unrestricted"), meaning USAID is willing to consider for-profit and non-profit entities, faith-based organizations, and public and private organizations. The initial entry point is an Expression of Interest (EOI), after which USAID expects to invite selected parties into a collaborative co-creation process around specific problem and challenge statements described in the BAA. This structure is meant to move faster and use resources more efficiently by refining concepts collaboratively rather than requiring fully formed proposals upfront.
Key opportunity details from the notice include: Funding Opportunity Title: Accelerator to End TB in India Broad Agency Announcement (BAA); Funding Opportunity Number: BAA ROAA ENDTB 2019; Agency: USAID/New Delhi (Agency for International Development, India); Activity Category: Health; CFDA: 98.001; Expected Awards: 4. The posting lists an award ceiling of 0, which typically signals that funding levels are not specified in the synopsis and may depend on the final co-created designs, negotiated budgets, or the chosen instrument(s). The opportunity was created April 11, 2019, with an original closing date of May 10, 2019.
Overall, this BAA is aimed at organizations that can bring strong, testable ideas plus real implementation capability and a willingness to share resources. The best fit is likely a consortium or partnership that can combine technical TB expertise, innovation and R&D capacity, behavioral and human-centered design strengths, and deep on-the-ground delivery reach in India, especially for MDR/RR-TB and for populations that face the greatest barriers to care.Apply for BAA ROAA ENDTB 2019
- The Agency for International Development, India USAID-New Delhi in the health sector is offering a public funding opportunity titled "Accelerator to End TB in India Broad Agency Announcement (BAA)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on Apr 11, 2019.
- Applicants must submit their applications by May 10, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the “Accelerator to End TB in India” Broad Agency Announcement (BAA)?
It is a USAID/New Delhi funding opportunity designed to identify partners to jointly build and test new approaches that can help India reach its goal of eliminating tuberculosis (TB) by 2025. Instead of funding a pre-defined project with fixed activities, this BAA is structured to attract strong ideas first and then work side-by-side with selected organizations to co-create and co-design solutions.
2) What is the main purpose of this opportunity?
The central purpose is to accelerate reductions in TB in India through person-centered, high-impact, and novel solutions. A particular focus is placed on multidrug-resistant and rifampicin-resistant TB (MDR/RR-TB), with an emphasis on generating evidence that can drive adoption at scale.
3) What kind of approaches is USAID looking for?
USAID is explicitly looking for “out-of-the-box, but achievable” approaches rather than incremental improvements. The emphasis is on research and development (R&D) interventions that can be demonstrated quickly and evaluated rigorously under real service delivery conditions, with measurable improvements in the patient journey and outcomes.
4) Does this BAA fund a pre-designed program with a fixed workplan?
No. The opportunity is set up to identify promising ideas and then collaborate with selected organizations through co-creation and co-design. The goal is to refine and develop concepts collaboratively rather than requiring fully formed proposals upfront.
5) What is meant by “person-centered” solutions in this BAA?
“Person-centered” implies innovations that materially improve the patient journey across key steps, such as risk identification and screening, diagnosis, treatment initiation, adherence support, and final outcomes. The focus is on practical improvements that patients experience within real-world systems.
6) What disease areas and populations are prioritized?
The BAA prioritizes TB in India, with a specific focus on MDR/RR-TB. Equity and access are described as non-negotiable, including attention to priority and vulnerable populations who face barriers to TB services.
7) What are the thematic areas of interest under this BAA?
USAID highlights several areas, including: (a) strengthening the enabling environment (such as policy, financing, regulation, data use, procurement and supply chains, quality standards, and coordination across public and private sectors); (b) enhancing service delivery platforms (such as referral pathways, differentiated care models, diagnostic access, treatment support, and integration with other health services); and (c) integrating modern behavior change approaches with scientific or technological advances.
8) What does “strengthening the enabling environment” include?
This can include improvements related to policy, financing, regulation, data use and decision-making, procurement and supply chains, quality standards, and coordination across public and private sectors. The intention is to make the broader TB ecosystem more supportive of effective prevention, diagnosis, and treatment approaches.
9) What does “enhancing service delivery platforms” mean in practice?
It refers to solutions that improve how TB services are organized and delivered, such as better referral pathways, differentiated care models, improved access to diagnostics, stronger treatment support mechanisms, and integration of TB services with other health services.
10) Is technology alone enough to be competitive?
The BAA suggests a preference for solutions that combine modern behavior change approaches with scientific or technological advances. In other words, a tool or technology by itself is unlikely to be the point; USAID is signaling interest in approaches that integrate human-centered design and behavioral insights alongside diagnostics, digital systems, or other innovations.
11) How important are equity and access in this opportunity?
Equity and access are positioned as essential for long-term success. The BAA calls for a clear understanding of how TB services will be accessible for everyone, including priority and vulnerable populations.
12) Does USAID expect local partnerships in India?
Yes. The opportunity emphasizes building diverse local partnerships to catalyze implementation. This reflects a preference for approaches grounded in local realities and able to operate within India’s TB ecosystem across government, private providers, communities, and other stakeholders.
13) What is “co-investment,” and why is it a defining feature of this BAA?
Co-investment means USAID wants partners to share responsibility, risk, and resources to reach agreed outcomes. The BAA is designed for joint problem-solving and co-creation, and co-investment aligns incentives and strengthens the likelihood that solutions can be adopted and scaled.
14) What types of resources can count as co-investment?
Co-investment can be cash or non-cash contributions. Examples listed include in-kind support, staff expertise, intellectual property, brand value, coordination capacity, and access to key networks, institutions, geographies, or data.
15) Is a 1:1 cost match required?
No. USAID does not require a 1:1 match. The expectation is that each party contributes resources appropriate to the specific project and aligned with their comparative advantage.
16) Who is eligible to apply?
Eligibility is described as “unrestricted.” USAID indicates it is willing to consider for-profit and non-profit entities, faith-based organizations, and public and private organizations.
17) What is the first step to engage with this opportunity?
The initial entry point is an Expression of Interest (EOI). After EOIs are reviewed, USAID expects to invite selected parties into a collaborative co-creation process around specific problem and challenge statements described in the BAA.
18) Why does the process start with an Expression of Interest instead of a full proposal?
The BAA structure is intended to move faster and use resources more efficiently by refining concepts collaboratively. It reduces the need for applicants to develop fully formed proposals before USAID and selected partners co-design the best path forward.
19) What is the expected number of awards?
The notice indicates an expectation of 4 awards.
20) What are the key identifiers for this funding opportunity?
The Funding Opportunity Title is “Accelerator to End TB in India Broad Agency Announcement (BAA).” The Funding Opportunity Number is “BAA ROAA ENDTB 2019.” The agency is USAID/New Delhi (Agency for International Development, India). The activity category is Health, and the CFDA number is 98.001.
21) What does it mean that the award ceiling is listed as 0?
The posting lists an award ceiling of 0, which typically signals that funding levels are not specified in the synopsis. In this kind of setup, funding levels may depend on the final co-created design, negotiated budgets, and/or the instrument(s) chosen.
22) When was the opportunity posted and when did it close?
The opportunity was created on April 11, 2019, and the original closing date listed was May 10, 2019.
23) What makes a strong-fit organization or partnership for this BAA?
The strongest fit is likely an organization or consortium that combines testable innovation ideas with real implementation capability in India and a willingness to share resources. The notice suggests value in combining TB technical expertise, innovation and R&D capacity, behavioral and human-centered design strengths, and on-the-ground delivery reach, especially for MDR/RR-TB and populations facing the greatest barriers to care.
24) What kind of evidence is USAID expecting from supported solutions?
USAID emphasizes interventions that can be demonstrated quickly and evaluated rigorously. The expectation is that results will generate credible evidence that can inform decisions and drive real-world adoption at scale under service delivery conditions.
25) Are incremental improvements to existing TB programs a fit?
The BAA signals that incremental improvements are not the goal. USAID is looking for novel approaches that can “leapfrog” conventional models for TB prevention, diagnosis, and treatment.
Browse more opportunities from the same category: Health
Next opportunity: OVC FY 2019 Advancing the Use of Technology to Assist Victims of Crime
Previous opportunity: GLNF-CESU Conduct Deer Survey on NMI-SLBE
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for BAA ROAA ENDTB 2019
Applicants also applied for:
Applicants who have applied for this opportunity (BAA ROAA ENDTB 2019) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technical Assistance for Response to Public Health or Healthcare Crises: HURRICANE SUPPLEMENTAL Apply for CDC RFA OT18 18040102SUPP19 Funding Number: CDC RFA OT18 18040102SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $650,000 |
| Availability of funds for Title X Family Planning– Innovations in Family Planning Clinical Service Delivery and Studies to Address Opportunities and Barriers for Linking Family Planning Services and Substance Use Disorder Screening and Treatmen Apply for PA FPR 19 001 Funding Number: PA FPR 19 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $800,000 |
| Medical Student Education Program Apply for HRSA 19 101 Funding Number: HRSA 19 101 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH15 16320101SUPP19 Funding Number: CDC RFA GH15 16320101SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $5,000,000 |
| Limited Competition: Interdisciplinary Complementary and Integrative Health Clinical Research Training (T90/R90 Independent Clinical Trial Not Allowed) Apply for RFA AT 19 010 Funding Number: RFA AT 19 010 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Minority Research Grant Program Apply for CMS 1W1 19 002 Funding Number: CMS 1W1 19 002 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $250,000 |
| Pediatric Environmental Health Specialty Units (PEHSU) Apply for CDC RFA TS19 1901 Funding Number: CDC RFA TS19 1901 Agency: Department of Health and Human Services, Centers for Disease Control - ATSDR Category: Health Funding Amount: $3,500,000 |
| Living Independently and Being Included in the Community (LIBC) Apply for 72036719RFA00003 Funding Number: 72036719RFA00003 Agency: Agency for International Development Category: Health Funding Amount: $1,000,000 |
| Strengthening Public Health Capacity and Guidelines to prevent, detect and control the spread of epidemic prone infectious diseases through Cooperation and Support from World Health Organization (WHO) Apply for CDC RFA GH19 1967 Funding Number: CDC RFA GH19 1967 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Rural Communities Opioid Response Program - Medication-Assisted Treatment Expansion (RCORP-MATE) Apply for HRSA 19 102 Funding Number: HRSA 19 102 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $725,000 |
| Rural Communities Opioid Response Program – Rural Centers of Excellence on Substance Use Disorders Apply for HRSA 19 108 Funding Number: HRSA 19 108 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $6,600,000 |
| Office of Urban Indian Health Programs 4-in-1 Grants, second opportunity Apply for HHS 2019 IHS UIHP2 0002 Funding Number: HHS 2019 IHS UIHP2 0002 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $578,561 |
| Urban Indian Education and Research Program Apply for HHS 2019 IHS UIHP3 0001 Funding Number: HHS 2019 IHS UIHP3 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $1,050,000 |
| Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health Apply for CDC RFA OT18 18020201SUPP19 Funding Number: CDC RFA OT18 18020201SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $10,000,000 |
| Emergency Department Surveillance of Nonfatal Suicide-Related Outcomes (ED-SNSRO) Apply for CDC RFA CE19 1906 Funding Number: CDC RFA CE19 1906 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $200,000 |
| Strengthening the Diagnostic Transport Network in Liberia Apply for CDC RFA GH19 1961 Funding Number: CDC RFA GH19 1961 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $2,000,000 |
| Strengthening Laboratory, Blood Safety, and Infection Prevention and Control Capacities in Liberia Apply for CDC RFA GH19 1962 Funding Number: CDC RFA GH19 1962 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| National Harm Reduction Technical Assistance and Syringe Services Program (SSP) Monitoring and Evaluation Funding Opportunity Apply for CDC RFA PS19 1909 Funding Number: CDC RFA PS19 1909 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in Panama and Other Countries in the Americas Apply for RFA IP 20 001 Funding Number: RFA IP 20 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,000,000 |
| Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement Apply for CDC RFA OT18 18030201SUPP19 Funding Number: CDC RFA OT18 18030201SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "BAA ROAA ENDTB 2019", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.